Simian immunodeficiency viruses infecting sooty mangabeys (SIVsmm) gave rise to nine groups of human immunodeficiency virus type 2 (HIV-2). Two of these (A and B) spread substantially with an estimated 1-2 million individuals affected. The evolutionary adaptations that facilitated HIV-2's spread in humans are still poorly understood. Here, we report that diverse SIVsmm strains efficiently infect primary human T cells. However, they are more sensitive to interferon than HIV-2, indicating that interferon-stimulated genes (ISGs) pose a barrier to the successful spread of SIVsmm in humans. One of the best-known antiviral ISGs is the zinc finger antiviral protein (ZAP), which targets CpG dinucleotides in RNA. To evade ZAP-mediated restriction, many viruses, including HIV-1, suppress their CpG content. Unexpectedly, we found that HIV-2 is more resistant to ZAP restriction than HIV-1 and SIVsmm despite having 33% more CpGs. Identification of ZAP-binding sites using RNA enhanced crosslinking immunoprecipitation and analyses of chimeric HIV-2/SIVsmm viruses revealed that the determinants of ZAP resistance map to the nef/U3 region and promote HIV-2 replication in primary human T cells. Our results indicate that HIV-2 evolved a CpG-independent ZAP resistance mechanism which might have been facilitated by relaxed functional constraints acting on Nef in the human host.
HIV-2 evades restriction by ZAP through adaptations in the U3 LTR region despite increased CpG levels.
尽管 CpG 水平升高,HIV-2 仍可通过 U3 LTR 区域的适应来逃避 ZAP 的限制
阅读:4
作者:Kmiec Dorota, Nchioua Rayhane, Gabel Alexander, Vlachou Asimenia, Ganskih Sabina, Erdemci-Evin Sümeyye, A Lapp Stacey, G Carnathan Diane, E Bosinger Steven, Berkhout Ben, T Das Atze, Munschauer Mathias, Kirchhoff Frank
| 期刊: | Nucleic Acids Research | 影响因子: | 13.100 |
| 时间: | 2025 | 起止号: | 2025 Aug 27; 53(16):gkaf826 |
| doi: | 10.1093/nar/gkaf826 | 研究方向: | 其它 |
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
